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The link between bacteria and host chromatin remodeling is an emerging topic. The exciting recent discov-
eries on bacterial impact on host epigenetics, as discussed in this Review, highlight yet another strategy used
by bacterial pathogens to interfere with key cellular processes. The study of how pathogens provoke host
chromatin changes will also provide new insights into host epigenetic regulation mechanisms.Introduction
The long coexistence of bacterial pathogens with their eukary-
otic hosts, and their coevolution, have provided pathogens
with an amazing capacity to exploit host cell functions for sur-
vival, replication inside or outside cells, and escape from early
innate immune responses. The fact that bacteria are so well
adapted to their host has been of great benefit for cell biologists
who are increasingly using them to study fundamental cell pro-
cesses. In this Review, we will discuss the emergence of chro-
matin modification as a mechanism by which bacteria affect their
host. Similar to viruses, bacteria provoke histone modifications
and chromatin remodeling in infected cells, thereby altering the
host’s transcriptional program and in most cases dampening
the host innate immune response. We will review our present
knowledge of the effects of lipopolysaccharide (LPS), Mycobac-
teria, Shigella, Listeria, and Helicobacter on histones and chro-
matin. The particular case of tolerance to LPS is discussed. In
addition, we report on bacterial homologs of eukaryotic chroma-
tin-binding proteins, whose activity on eukaryotic targets are yet
to be demonstrated.
Chromatin, Nucleosomes, and the Histone Code
Eukaryotic cells are faced with the challenge of packaging large
amounts of DNA into the confined space of the nucleus, without
compromising the crucial properties of DNA in various pro-
cesses such as replication, repair, transcription, and also chro-
mosome segregation. This important requirement is achieved
by two classes of proteins, histones and chromatin-remodeling
proteins, which compact DNA into a highly organized structure
called chromatin. The first step in chromatin formation is the
wrapping of 147 nucleotide pairs of DNA (1.7 turns) around an
octamer of four core histones—H2A, H2B, H3, and H4 (Fig-
ure 1A). This structure, the nucleosome, defines the basic unit
of chromatin and repeats at intervals of approximately 200
base pairs. Another histone, H1, stabilizes the DNA around the
core histones and further compacts DNA by looping of nucleo-
somes on top of each other. During mitosis, DNA becomes fur-
ther compacted into mitotic chromosomes, allowing for proper
segregation of the replicated chromosomes. However, the pre-
cise folded and looped structure of the DNA in the nucleus
in vivo is still a matter of debate, probably because this structure
is very dynamic, constantly undergoing remodeling allowing for100 Cell Host & Microbe 4, August 14, 2008 ª2008 Elsevier Inc.transcription, repair, or cell division to take place (Tremethick,
2007).
The interphase DNA is organized into two chromatin states—
the heterochromatin and the euchromatin, which differ in their
level of compaction. It is believed that the position of a gene in
either hetero- or euchromatin will define its expression state. In-
deed, heterochromatin is the denser of the two states, with most
of the DNA present in this structure being silent. In fact, hetero-
chromatin is found at centromeres, which are gene-poor re-
gions, in the inactive X chromosome, at repeats dispersed
throughout the chromosomes, and at cell type specific genes
silenced during development. In contrast, euchromatin is much
less condensed, and DNA in this state is poised for transcription.
Yet, the two chromatin states are not static, and many factors
contribute to chromatin dynamics.
Chromatin dynamics is orchestrated by chromatin-remodeling
complexes and histone-modifying enzymes. Chromatin-remod-
eling complexes utilize ATP hydrolysis to unwind DNA and/or
reposition nucleosomes allowing for the underlying DNA to be-
come accessible or inaccessible for processes such as gene ex-
pression, DNA replication, repair, or recombination. Currently,
remodeling complexes are organized into four classes defined
by their ATPase subunit: SWI/SNF, ISWI, Mi-2, and Ino80.
Each of these complexes interact with sequence-specific DNA-
binding factors at the targeted genes and can have both a posi-
tive and a negative role on transcription (reviewed in Mohrmann
and Verrijzer, 2005).
Histone-modifying enzymes are also crucial for conferring the
dynamic nature of chromatin. Indeed, core histones are subject
to a vast array of covalent modifications, including phosphoryla-
tion, acetylation, methylation, and ubiquitylation, which occur
mostly on the N-terminal tails, but also occur in the histone core
(Figure 1B). These modifications are dynamic and reversible,
and enzymes that either induce or remove the modifications
have been identified. Histone modifications regulate transcription
either by affecting the chromatin structure directly, i.e., by chang-
ing the interactions of histones with DNA, and/or by recruiting
nonhistone proteins such as transcription factors (Kouzarides,
2007). Therefore, the combination of different histone modifica-
tions, which has been called the ‘‘histone code,’’ adds an addi-
tional level of transcriptional regulation besides regulation by ac-
tivators or repressors at the promoter level (Strahl and Allis, 2000).
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nowpossible toassociatea specific modification witha transcrip-
tional state. Methylation, which can occur on either a lysine or
an arginine residue, is the best-characterized modification to
date (reviewed in Shilatifard, 2006). Methylation is associated
with either transcriptional activation or repression depending on
the lysyl residue modified and whether this residue is mono-,
di-, or trimethylated. For instance, trimethylation (and not mono-
or di-) of histone H3 on lysine 9 (H3K9) is associated with repres-
sion, heterochromatin formation, and DNA methylation. The
repression by H3K9 also involves the recruitment of the hetero-
chromatin protein 1 (HP1), a protein responsible for forming and
propagating heterochromatin. Interestingly, many of the proteins
identified as histone methyltransferases also methylate a variety
of nonhistone substrates, implicating these proteins in signaling
cascadesand processes independent of transcriptional regulation
(Rathert et al., 2008, and references within). Another well-de-
scribed mark, acetylation, which is also a modification found on
lysine residues, has been mostly shown associated with active
transcription. It is thought that acetylation renders chromosomal
domains more accessible to the transcription machinery. How-
ever, a direct role for histone acetylation in recruiting the tran-
scription machinery has not been shown, and it remains possible
that this mark arises as a consequence of active transcription
rather than as a prerequisite for transcriptional activation. Fur-
thermore, similarly to methyltransferases, histone acetyltrans-
ferases can modify lysines on various histones and nonhistone
proteins (reviewed in Kouzarides, 2000).
A list of histone modifications and their correlation with tran-
scriptional activation or repression is shown in Figure 1B and is
Figure 1. Nucleosome Structure and
Histone Tail Modifications
(A) The arrangement of the eight histone proteins
in the nucleosome is shown schematically. One
hundred and forty-seven base pairs of DNA are
wrapped around the histone core. Histone H1
seals the nucleosome separating each nucleo-
some unit from each other.
(B) Covalent modifications of histone tails as listed
per histone. The sequences of the N-terminal tails
of histones are shown with amino acid position in-
dicated in gray underneath. Modifications shown
above the sequence are associated with an activa-
tion of transcription and those indicated beneath
are associated with transcriptional repression.
reviewed in Kouzarides (2007). However,
many recent studies show that any given
modification has the potential to both
activate or repress transcription, and it is
the context in which they are found—i.e.,
the surrounding modifications—that is
important for determining their function.
Not only is the meaning of the histone
code becoming clear but also the mech-
anisms by which histone modifications
appear. Cellular stimuli are integrated
through signal-transduction pathways,
culminating in activation of histone
modifying enzymes and modification of
histones. Among them, the best- characterized link between
a stimulus and its effect on histones is the MAPK (mitogen-ac-
tivated protein kinase) cascade, which upon activation leads to
phosphorylation of histone H3 on serine 10 (H3S10). Three MAP
kinase cascades have been defined according to the MAP ki-
nase that is activated: the ERK pathway, the JNK/SAPK path-
way, and the p38 kinase pathway, each responding to a different
stimulus (including stress, growth factor, and differentiation fac-
tor signals). Both the ERK and p38 kinases have been shown to
activate effector kinases, MSK1 and MSK2, which will directly
phosphorylate H3S10 at the promoter of activated genes (Clay-
ton and Mahadevan, 2003; Mahadevan et al., 1991; Thomson
et al., 1999). The time course of H3 phosphorylation closely
correlates with the timing of gene activation, suggesting a link
between this modification and transcriptional activation; how-
ever, the exact role of this modification in gene expression
remains unclear. The current hypothesis is that phosphorylation
of H3S10 is a predisposing mark for acetylation, itself a mark for
active transcription (Cheung et al., 2000). It should be noted that,
independently of its role in transcription, H3S10 has also been
shown to be important for mitotic chromatin condensation
(Cheung et al., 2000) (Figure 2). How this single modification
can lead to unwinding of DNA for transcription and condensa-
tion for mitosis remains to be elucidated.
Phosphorylation of H3S10, upon activation of MAPKs, was
shown to occur in a promoter-specific manner, targeting only
a subset of genes (Clayton and Mahadevan, 2003). This specific-
ity of histone modifications to subsets of promoters has long
been puzzling. Recently, reports have shown data supporting
a model in which MAPKs present in chromatin-modifying andCell Host & Microbe 4, August 14, 2008 ª2008 Elsevier Inc. 101
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munds and Mahadevan, 2004; Pokholok et al., 2006; Simone
et al., 2004). Genome occupancy by MAPK thus constitutes
a new perception of how these signaling cascades work with
the consequence that regulation occurs at the targeted genes
themselves and in a gene-specific manner.
It has increasingly become clear that histone modifications
and chromatin structure are key regulators of eukaryotic tran-
scription and, thus, good targets for pathogens during an infec-
tion. In fact, viruses have long been described as able to manip-
ulate the host chromatin to impose a transcriptional program
beneficial for the maintenance of infection (Lieberman, 2006).
Recent reports show that bacterial pathogens are also able to
induce chromatin remodeling, thereby imposing a specific
transcriptional profile. We review here the first reports on this
emerging field of study, which highlight novel aspects of host-
pathogen interactions.
Histone Modifications and Chromatin Remodeling
Provoked by Bacteria
Various bacterial products or secreted factors may induce chro-
matin/histone modifications, involving different host signaling
cascades (Figures 3 and 4).
Figure 2. Dual Role of Phosphorylated Serine 10 on Histone H3
in Transcription and in Mitosis
During interphase, mitogenic signals (which include stress, growth factor, and
developmental factor signals) activate MAPK signaling culminating in translo-
cation of the MAPKs to the nucleus, where they activate a downstream kinase
(MSK1 or MSK2) leading to phosphorylation of H3S10. This mark is thought to
be a predisposing mark for acetylation and transcriptional activation.
During mitosis, H3S10 becomes phosphorylated by specific mitotic kinases,
leading to chromosomal condensation and proper cell division.102 Cell Host & Microbe 4, August 14, 2008 ª2008 Elsevier Inc.A. LPS, Tolerance, and TLR-Induced Chromatin
Modification (Figure 3)
Innate immunity is the first line of defense against a bacterial in-
fection, and most organisms are able to mount an efficient early,
nonspecific response leading to the recruitment of cellular effec-
tors and inflammation. Microbial components that elicit an
inflammatory response have been called microbial associated
molecular patterns (MAMPs) and include LPS, bacterial flagellin,
lipoteichoic acid, peptidoglycan, and nucleic acids. Host cells
recognize MAMPs through pattern recognition receptors
(PRRs) present either at the cell surface and/or on endosomes,
for Toll-like receptors (TLRs), or in the cytoplasm, for nucleo-
tide-binding oligomerization domain proteins (NODs) and NOD-
like receptors (NLRs). These receptors activate signaling cas-
cades leading to transcriptional activation of immunity genes
such as cytokine genes (reviewed in Akira and Takeda, 2004;
Kanneganti et al., 2007).
LPS is the major component of the outer membrane of Gram-
negative bacteria and is one of the best-characterized agonist of
host inflammatory signaling responses. LPS is recognized by
TLR4, and downstream signaling includes activation of the
nuclear factor-kB signaling cascade (NF-kB), activation of all
three MAPK cascades, and increased transcription of genes
for proinflammatory cytokines such as interleukin-12 (IL-12),
IL-6, and tumor-necrosis factor (TNF) (Akira and Takeda, 2004).
The first link between LPS stimulation and chromatin remodel-
ing has been established through the study of a gene activated
by LPS, the IL-12 cytokine gene. This cytokine is produced by
activated macrophages and dendritic cells and is required for
the activation of T cells. It has been shown that a nucleosome
spans the promoter of the IL-12 gene, which is displaced upon
LPS stimulation, thereby allowing transcription to occur (Wein-
mann et al., 1999). Nucleosome repositioning by LPS occurred
in a TLR4-dependent manner and correlated with histone H3
and H4 acetylation at the IL-12 promoter (Weinmann et al.,
2001). From these data, it was first suggested that LPS stimula-
tion of TLR4 induces histone acetylation and nucleosome
remodeling, allowing for NF-kB to gain access to the IL-12 pro-
moter. One year later, another group elucidated the mechanism
underlying chromatin remodeling and NF-kB accessibility at the
IL-12 promoter and other NF-kB-dependent promoters (Saccani
et al., 2002). The authors showed that activation of the p38
MAPK pathway upon LPS stimulation of TLR4 induced phos-
phorylation of H3S10 and phosphorylation/acetylation (S10/
K14) of H3 (phosphorylation at serine 10 and acetylation on
lysine 14 of the same histone tail), which were crucial modifica-
tions for recruiting NF-kB to the promoter of certain genes,
such as IL-12. Therefore, the current model is that some NF-kB-
activated genes require phosphorylation of H3S10 and phos-
phoacetylation of H3S10K14 via the p38 MAPK pathway so
that their promoters become accessible to NF-kB, allowing
transcription to occur. However, Saccani et al. also identified
MAPK-independent mechanisms of phosphorylation of H3S10
and p38- and phosphorylated H3S10-independent mechanisms
of gene activation, suggesting that there are at least two other
modes of NF-kB-dependent gene activation (Saccani et al.,
2002).
LPS induction of TLR4 and expression of inflammatory cyto-
kines and chemokines is of great importance for the host to clear
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matory factors is detrimental to surrounding tissues. Therefore,
a tight downregulation of the inflammatory response occurs,
with repressed expression of the proinflammatory genes, a
phenomenon named LPS or endotoxin tolerance, and is associ-
ated with immunosuppression and poor prognosis (Cavaillon and
Adib-Conquy, 2006). This tolerance has in two cases been shown
to be controlled by epigenetic changes involving heterochroma-
tin binding protein 1a (HP1a), methylation of H3K9, reduced
phosphorylation of H3S10, and diminished binding of NF-kB at
the promoter of inflammatory genes (El Gazzar et al., 2007;
Chan et al., 2005). Importantly, LPS tolerance negatively affects
proinflammatory mediators without inhibiting antimicrobial effec-
tors. Interestingly, the two classes of promoters, those of
proinflammatory mediator genes and those of antimicrobial
effector genes, which both show histone acetylation and H3
trimethylation on lysine 4 upon initial exposure to LPS, are later
distinguished by the modification of their histones (Foster et al.,
2007). Indeed, with prolonged exposure, the histones at the
silenced genes become deacetylated, while those at genes that
remain inducible stay highly acetylated. Another report supports
these findings by showing that prolonged exposure to LPS leads
to transcriptional activation of multiple histone deacetylases
(HDACs), each being recruited at a different promoter (Aung
Figure 3. Schematic Representation of
Mycobacterium-Induced Signaling as
Described in the Text
et al., 2006). Together, these reports sug-
gest that inflammatory genes are regu-
lated at a gene-specific level and not
strictly by a signaling cascade-specific
mechanism. This novel way of viewing sig-
naling cascades implies that even though
a large number of genes are regulated by
the same signaling cascade, thereare pro-
moter-specific mechanisms that fine tune
the expression of each individual gene.
B. Mycobacterium Tuberculosis,
Histone Deacetylation, and
Inhibition of the Normal IFN-g-
Induced Response (Figure 3)
Mycobacterium tuberculosis is the causa-
tive agent of tuberculosis, responsible for
approximately 3 million deaths a year
across the world. Most infected individ-
uals are able to clear the infection. How-
ever, 10% of them are unable to contain
it and develop an active disease, despite
an apparently healthy immune system. If
theM. tuberculosis infection is not cleared,
a long-term chronic infection persists, har-
bored by macrophages. An important
challenge in the study of M. tuberculosis
is to understand how this bacterium
avoids destruction by the immune system.
One of several immune effectors im-
portant for controlling a M. tuberculosis
infection is IFN-g, a cytokine secreted by activated T cells and
natural killer cells, and whose major role is to induce expression
of the major histocompatibility complex class II (MHC class II) on
the surface of various cell types (Boehm et al., 1997). Upon bind-
ing of IFN-g to its cell-surface receptor, the Janus tyrosine kinase
(JAK) is activated, leading to phosphorylation of STAT1 (signal
transducer and activator of transcription), which translocates
into the nucleus and mediates transcription of several genes
including that of the transactivator CIITA, itself necessary for
transcription of the genes involved in the MHC class II complex
formation.
Strikingly, M. tuberculosis is able to inhibit IFN-g responses
at the level of mRNA expression of IFN-g-responsive genes.
M. tuberculosis targets a subset of IFN-g-induced genes, includ-
ing CIITA, CD64, and HLA-DR, while others are unaffected,
and this occurs despite normal activation of the JAK/STAT1
pathway (Kincaid and Ernst, 2003). These findings suggested
promoter-specific mechanisms of transcription inhibition, which
are starting to become understood. Two different mechanisms
were recently identified, each having an effect on a different
IFN-g-regulated promoter and both involving histone modifica-
tions and chromatin remodeling.
One mechanism was studied at the promoter of the gene
encoding the IFN-g-regulated gene, CIITA. In uninfected cells,Cell Host & Microbe 4, August 14, 2008 ª2008 Elsevier Inc. 103
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of the SWI/SNF chromatin-remodeling complex, and of CBP
(CREB-binding protein), a transcriptional coactivator and his-
tone acetyl transferase, leading to transcription of CIITA (Pat-
tenden et al., 2002; Kretsovali et al., 1998). However, upon
infection with M. tuberculosis, or upon incubation with the my-
cobacterial cell wall protein, LpqH, the IFN-g-induced transcrip-
tion of CIITA is blocked (Pennini et al., 2006 and references
therein). The mechanism by which CIITA transcription is blocked
occurs through inhibition of SWI/SNF binding and histone
deacetylation at the CIITA promoter (Pennini et al., 2006). In cor-
relation with inhibition of IFN-g-induced CIITA transcription,
LpqH induced binding of the C/EBP (mostly C/EBP-b LIP) tran-
scriptional repressor to the promoter of CIITA (Pennini et al.,
2007). The exact mechanism by which histone acetylation,
SWI/SNF, and C/EBP control CIITA transcription has not been
elucidated. One plausible hypothesis is that M. tuberculosis
induces the recruitment of C/EBP for repression of transcription.
In agreement with this hypothesis, C/EBP has previously been
shown to recruit a HDAC at the promoter of an unrelated gene,
thereby inhibiting transcription (Di-Poi et al., 2005).
The other report analyses the downregulation of IFN-g-depen-
dent HLA-DR transcription by mycobacteria (Wang et al., 2005).
HLA-DR is a MHC class II surface protein. Transcriptional activa-
tion of HLA-DR requires CIITA, which functions as a transcrip-
Figure 4. Schematic Representation of
Shigella, Listeria, andHelicobacter-Induced
Signaling as Described in the Text
tional coactivator and coordinates his-
tone acetylation at the promoter either
directly through intrinsic HAT activity, or
by recruiting HATs, such as CBP (Beres-
ford and Boss, 2001; Kretsovali et al.,
1998), while transcriptional shutoff re-
quires the HDACs/mSin3A corepressor
complex (Zika et al., 2003). Upon infec-
tion with M. tuberculosis, IFN-g-induced
histone acetylation at the HLA-DR
promoter was impaired, and HLA-DR ex-
pression was inhibited (Wang et al.,
2005). Although IFN-g-dependent CIITA
expression was lower in infected cells
compared to noninfected cells, the con-
centration of CIITA was considered suffi-
cient to induce HLA-DR expression,
suggesting a promoter-specific mecha-
nism keeping HLA-DR expression low in
infected cells. Indeed, in infected cells,
the mSin3A repressor was recruited to
the HLA-DR promoter, with a coordinate
loss of CBP binding. The authors hypoth-
esize that mSin3A could compete with
CBP for binding to the HLA-DR promoter,
and depending on binding of one or the
other, transcription would be activated
or repressed, and histones acetylated or
deacetylated. How M. tuberculosis induces the repressor
recruitment remains to be determined.
Interestingly, both mechanisms described above were found
to be TLR2 dependent, even though the link between TLR2 acti-
vation and histone deacetylation remains unknown. Pennini et al.
showed that activation of the TLR2 pathway induced the p38 and
ERK1/2 MAPK signaling cascades (Pennini et al., 2006).
However, the well-described role of MAPKs on histones is phos-
phorylation, a precursor mark for acetylation (Edmunds and
Mahadevan, 2004). Furthermore, activation of MAPKs leads to
recruitment of HATs to specific promoters, and to an increase
in the intrinsic HAT activity of certain transcription factors, such
as ATF-2 (Edmunds and Mahadevan, 2004). Up to now, there
has been only one report of MAPK activation leading to recruit-
ment of HDACs, thereby having a repressive activity on gene
transcription (Yang et al., 2001). Whether this repressive mecha-
nism by MAPKs is at play during infection with M. tuberculosis
remains to be investigated.
C. Shigella flexneri and inhibition of the p38 MAPK
(Figure 4)
Shigella flexneri is the causative agent of bacillary dysentery,
which causes more than a million deaths a year, mostly in chil-
dren of the developing world. This facultative intracellular
pathogen is able to induce its own uptake into colonic epithelial
cells through a type III secretion system, and survive inside104 Cell Host & Microbe 4, August 14, 2008 ª2008 Elsevier Inc.
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mount an important innate immune response crucial for clear-
ance of S. flexneri.
In a recent publication a new mechanism of host subversion by
S. flexneri has been identified: alteration of the chromatin struc-
ture leading to modulation of the host transcriptional response
(Arbibe et al., 2007). During a S. flexneri infection, the type III se-
cretion effector OspF migrated to the nucleus of the host cell
where it specifically targeted the ERK and p38 MAPKs for de-
phosphorylation, but not the JNK MAPK. As a consequence,
OspF prevented MAPK-dependent phosphorylation of H3S10
at the promoter of a specific subset of genes. It has been known
that H3 phosphorylation by MAPK signaling results not only in
activation of MAPK-regulated gene transcription, but also in
chromatin remodeling allowing for NF-kB to access certain pro-
moters (for activation of the p38 MAPK) (Saccani et al., 2002).
Consistent with this knowledge, the OspF-induced block of
MAPK induced H3 phosphorylation, correlated with impaired re-
cruitment of NF-kB to the promoter of the inflammatory cytokine
IL-8. Therefore, by inactivating ERK and p38, OspF blocked
phosphorylation of H3 and inhibited transcriptional activation
of important immunity genes, such as IL-8.
Given that OspF was shown to dephosphorylate ERK and p38,
a primary assumption was made that OspF was a dual specificity
phosphatase (Arbibe et al., 2007). However, a recent report us-
ing mass spectrometry showed that OspF was responsible for
dehydration of phophorylated ERK, as well as dephosphoryla-
tion (Li et al., 2007). This result, along with a detailed analysis
of the OspF sequence, ruled out OspF as a classical protein
phosphatase. Further biochemical experiments demonstrated
that purified OspF has phosphothreonine lyase activity, a unique
activity that has not previously been described for any protein
(Li et al., 2007; Zhu et al., 2007). This new enzymatic activity
chemically modifies carbon bonds of the substrate, leading to
irreversible inactivation of the ERK kinase and rendering ERK
non rephosphorylatable. This finding, in combination with the
role of OspF on transcription, suggests that OspF would block
IL-8 gene activation irreversibly. However, at 2 hr of infection
with wild-type S. flexneri, there is a 300-fold increase in IL-8 ex-
pression compared to noninfected cells (Pedron et al., 2003),
suggesting that other mechanisms are involved in IL-8 regula-
tion. Two hypotheses can be proposed to reconcile these
data: either (1) IL-8 expression is only induced in cells in which
OspF is not translocated or expressed; or (2) OspF expression
is transient during infection, and other signaling cascades over-
come the activity of OspF and induce expression of important
immunity genes. Interestingly, type III secretion effectors of
Salmonella typhimurium (SpvC) and Pseudomonas syringae
(HopA1) were also shown to have the same phosphothreonine
lyase activity as OspF (Li et al., 2007; Zhu et al., 2007; Chen
et al., 2008; Zhang et al., 2007), suggesting thatSalmonellamight
also have a similar effect on host cell histones and gene
expression.
D. Listeria monocytogenes, LLO,
and Other Bacterial Toxins (Figure 4)
Listeria monocytogenes is the causative agent of the foodborne
infection, listeriosis, which mainly affects immunocompromised
individuals, pregnant women, and newborns. Characteristic
manifestations of listeriosis are gastroenteritis, meningitis, en-cephalitis, mother-to-fetus infections, and septicaemia, resulting
in death of 25%–30% of patients. During infection, L. monocyto-
genes is adapted to cross the intestinal barrier and gain access
to internal organs. In severe infections, L. monocytogenes is able
to cross the blood-brain barrier, and in pregnant women, the
fetoplacental barrier, leading to infection of the brain and fetus
respectively.
L. monocytogenes has emerged as a multifaceted model,
which has led to important breakthroughs in host immunity,
cell biology, and cellular microbiology (Hamon et al., 2006). Re-
cently, two reports have described two different mechanisms by
which L. monocytogenes modifies histones during infection
(Schmeck et al., 2005; Hamon et al., 2007).
In one of the reports, L. monocytogeneswas shown to activate
p38 and ERK MAPK pathways after 30 min of infection in endo-
thelial cells (Schmeck et al., 2005). Correspondingly, this MAPK
activation correlated with an increase in lysine 8 acetylation on
H4 and serine 10 phosphorylation/lysine 14 acetylation of H3,
and transcriptional activation of MAPK induced genes, such as
IL-8 after 2 hr of infection. Genes that were not regulated by
MAPK, such as the IFN-g gene, showed no change in the level
of modified histone at their promoter, demonstrating that histone
modification is specific to MAPK-induced genes. Interestingly,
a followup study done by the same group demonstrated that
IL-8 activation only occurred when bacteria had entered the
host cytoplasm and that the NOD-1 protein was critical in
L. monocytogenes dependent secretion of IL-8 (Opitz et al.,
2006). These studies therefore show that in the cytoplasm,
NOD-1 activation by L. monocytogenes leads to histone modifi-
cations. Whether NOD-1 activation by other pathogens can also
lead to histone modifications, or whether this response is spe-
cific to L. monocytogenes remains to be determined. Interest-
ingly, this was the first report that suggested a link between
NOD activation and histone modifications.
In another report, L. monocytogenes was found to induce
a dramatic decrease in the level of phosphorylated H3S10 and
acetylated H4 in epithelial cells early on during infection, and in
contrast with the previously described report, did not require en-
try of L. monocytogenes into host cells (Hamon et al., 2007). In
fact, the secreted virulence factor listeriolysin O (LLO) was iden-
tified as a main effector and was sufficient for decreasing the
level of modified histones. LLO is an important toxin for lysis of
the vacuole, in which the bacterium is found once it has entered
the host cell, but additional potent signaling activities, indepen-
dent of its pore forming activity, have also been described for
this protein (Hamon et al., 2006). Since LLO inserts itself into
the membrane and is rapidly degraded in the cytoplasm of the
host (Schnupf and Portnoy, 2007), LLO probably affects host his-
tones through a signaling cascade. The signaling cascade acti-
vated by LLO to induce histone modifications has not yet been
identified, as none of the signaling cascades known to be acti-
vated by LLO seem to be involved in this effect (Hamon et al.,
2007). Furthermore, a transcriptome analysis of the host genes
whose expression is modulated by LLO did not reveal the role
for another signaling cascade. However, a number of LLO-
downregulated genes are involved in immunity, suggesting that
L. monocytogenes, through LLO, also has a chromatin-depen-
dent mechanism of altering immune gene expression. Strikingly,
this mechanism was not restricted to L. monocytogenes, andCell Host & Microbe 4, August 14, 2008 ª2008 Elsevier Inc. 105
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and extracellular bacteria, were found to have the same effect on
decreasing phosphorylated H3S10. For example, Clostridium
perfringens, through its toxin PFO, and Streptococcus pneumo-
niae, through PLY, could also modify host histones during infec-
tion. The molecular mechanism by which these toxins induce the
dramatic decrease in phosphorylated H3S10 will prove to be
interesting, as very few stimuli have been described as having
such an effect on histones (Hamon et al., 2007).
E. Helicobacter pylori and Expression of IL-6 (Figure 4)
Helicobacter pylori is a Gram-negative bacterium that colonizes
the human gastric mucosa. Infection by this bacterium occurs
through an oral-oral or fecal-oral mode, and usually persists
throughout the life of the patient. Chronic inflammation caused
by H. pylori infection results in chronic gastritis and peptic
ulcers.
IL-6 is one of the cytokines that is responsible for H. pylori in-
duced tissue invasion by macrophages, leading to inflammation,
and is overexpressed in the mucosa at the margin of gastric
ulcers. Recently, Pathak et al. identified a H. pylori factor,
HP0175, responsible for IL-6 expression and that has an effect
on histone modifications (Pathak et al., 2006). The authors
showed that HP0175, a TLR-4 interacting protein (Basak et al.,
2005), induced NF-kB, ERK, and p38 MAPK activation, which
were all necessary for IL-6 expression. Furthermore, IL-6 expres-
sion correlated with phosphorylation of H3S10 at the IL-6 pro-
moter, which required induction of ERK and p38 to in turn
activate MSK1, a serine kinase responsible for phosphorylating
H3S10. This modification was shown to be required for NF-kB-
dependent IL-6 expression upon TLR4 activation by HP0175. Al-
though MAPK-induced histone modifications allowing for NF-kB
binding had previously been described for TLR4 activation by
LPS (see LPS section of this Review), this is the first report linking
an H. pylori protein to histone modifications.
F. The commensal Bacteroides Vulgatus
Bacteroides vulgatus is a nonpathogenic commensal bacterium
that is part of the normal flora of healthy individuals. Resident
flora has been shown to have a crucial role in autoimmune disor-
ders such as inflammatory bowel disease. In these disorders, the
body mounts an immune response to the microbial community
colonizing the host intestine, while in healthy individuals, it is ‘‘si-
lent.’’ These observations show that commensal bacteria have
the ability to induce an immune response under certain condi-
tions, although they normally are maintained silent without
eliciting any response from the host.
Interestingly, a report has shown that normal intestinal homeo-
stasis between the commensal, B. vulgatus, and intestinal
epithelial cells involves chromatin modifications (Haller et al.,
2003). The authors demonstrated that commensals, including
B. vulgatus, have the potential to induce an inflammatory
response in vivo in intestinal epithelial cells by activating the
NF-kB pathway. However, B. vulgatus also activates the TGF-
b1 signaling pathway, which is an important downregulator of
host immune response to microorganisms. In fact, in vitro,
TGF-b1 inhibited B. vulgatus induced expression of the proin-
flammatory cytokine IL-6. The mechanism by which this oc-
curred was through inhibiting B. vulgatus-induced histone H3
phosphorylation/acetylation (S10/K9), leading to a decrease in
recruitment of NF-kB to the IL-6 promoter. Therefore, there106 Cell Host & Microbe 4, August 14, 2008 ª2008 Elsevier Inc.seems to be a tight balance between activation of IL-6 by NF-kB
and inhibition by TGF-b1 to maintain homeostasis.
Bacterial Proteins Able to Interact with Host Histones
Although it is becoming clear that modulation of host histones
and chromatin by bacterial pathogens is a widely spread mech-
anism, there is little, if any evidence that bacterial proteins
directly interact with host chromatin. Interestingly, homologs of
histone modification enzymes are quite common in bacteria,
but their in vivo function in most cases remains unknown. In
the next section we will describe the current knowledge on
such homologs.
A. An Agrobacterium Protein with Histone
Chaperone-like Activity
To date there has been only one report showing a direct interac-
tion between a bacterial protein, the Agrobacterium tumefaciens
6b protein, and eukaryotic chromatin resulting in chromatin
remodeling (Terakura et al., 2007). Agrobacterium tumefaciens
is a plant pathogen that induces the formation of tumors in its
host by injecting a plasmid, the Ti plasmid, which is integrated
into the host genome. Encoded on this plasmid is protein 6b,
which plays an important role in proliferation of plant cells, lead-
ing to tumor formation. Protein 6b interacts with histone H3 both
in vitro and in vivo. Furthermore, 6b appears to contribute to
nucleosome formation, suggesting that it has histone chaper-
one-like activity. A transcriptome analysis identified genes differ-
entially regulated in transgenic plants expressing 6b compared
to control plants, suggesting also a role for 6b in transcriptional
regulation. Despite these results, the exact role of protein 6b
remains to be determined, as no change in histone modification
was observed at the promoter of the genes identified as differen-
tially regulated.
B. In Vitro Activity of Bacterial Homologs
of Histone-Modifying Enzymes
Homologs of histone deacetylases (HDACs), acetyl transferases
(HATs), and methyltransferases have been found in bacteria and
are proposed to be the ancestors of their eukaryotic homologs.
However, as these enzymes have been shown in eukaryotes to
have other targets, it is possible that the bacterial homologs
have activities on other factors (see below). Interestingly, al-
though histone-like proteins have been described in bacteria
these proteins do not appear to be the precursors of eukaryotic
histones. Indeed, these proteins have only superficial similarity
to eukaryotic histones. They bear only similarities in DNA-binding
activity, molecular mass, and electrostatic charge. Furthermore,
so far, no covalent modification has been found associated with
these proteins suggesting that histone-like proteins are not
the substrates of the bacterial HDAC, HAT, or methyltransferase
homologs.
 HDAC Bacterial Homologs
Phylogenetic analyses show that bacterial HDACs precede
not only their eukaryotic counterparts, but histone proteins
themselves, inferring that the primary activity of bacterial
HDAC are directed against nonhistone substrates (Finnin et al.,
1999; Nielsen et al., 2005). In fact, in eukaryotes HATs and
HDACs have recently been shown to have other substrates be-
sides histones, which include DNA-binding proteins (transcrip-
tion factors), nonnuclear proteins (tubulin), and proteins that
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factors) (Kouzarides, 2000). Therefore, acetylation is emerging
as a regulatory mark similar to phosphorylation, which not only
controls transcription, but can also modify protein stability and
protein interactions through mechanisms not well understood
(Kouzarides, 2000). Bacterial homologs of eukaryotic HATs and
HDACs have been very useful for understanding the structure
and function of their eukaryotic homologs, and could also
be useful for deciphering this new and not well-understood
modification.
Bacterial homologs of all four classes of HDACs have been
found and are called acetylpolyamine amidohydrolases (APAH),
acetoin utilization proteins, or simply HDAC-like proteins. These
homologs have been used as model systems to study the molec-
ular mechanism by which HDAC proteins work. The first crystal
structures of HDAC proteins were obtained using bacterial
homologs to human HDAC. HDAC-like proteins of the hyperther-
mophilic bacterium Aquifex aeolicus was used as a class 1 hu-
man HDAC representative, and that of the bacterial pathogen
Bordetella, the causative agent of whooping cough, as a class
2 representative (Finnin et al., 1999; Nielsen et al., 2005). Both
of these crystal structures were solved in a complex with
a HDAC inhibitor, thereby identifying the binding pocket and
the residues important for catalytic activity. To date the endoge-
nous substrate(s) of the two HDAC-homologs remain unknown;
however, in vitro experiments show that they can acetylate his-
tones (Finnin et al., 1999; Nielsen et al., 2005). These findings
raise the possibility that if in contact with host histones, or
other acetylated eukaryotic protein, these enzymes could have
important regulatory roles.
 HAT Bacterial Homologs
The relationship between bacterial acetyl transferases and
eukaryotic HATs is less clear than for HDACs, as there seems
to be less homology between these families of proteins (Brad-
shaw et al., 1998). However, the three-dimensional structure of
the Salmonella enterica acetyltransferase, AAC(60)-ly, places
this enzyme in the acetyltransferase superfamily in which HATs
are present, suggesting that it might be the bacterial ancestor
of eukaryotic HATs (Vetting et al., 2004). In vitro studies show
that AAC(60)-ly can acetylate histone proteins and demonstrated
the chemical mechanism for the reaction, which was thus far un-
known. However, similarly to HDACs, the substrate for bacterial
HATs, such as AAC(60)-ly, remains unknown, and one could hy-
pothesize that if secreted and targeted to the host nucleus these
proteins could have important implications on transcriptional
regulation. Alternatively, a regulatory function on other host
substrates could also be very interesting and would constitute
a new mechanism of bacterial induced modification.
 Methyltransferase Bacterial Homologs
Methyltransferases that act on histones are part of a class of
methyltransferases with a characteristic SET domain. This SET
domain, which is the catalytic domain, differs widely in structure
from classical methyltransferases that act on a large variety of
other proteins (Aravind and Iyer, 2003). Phylogenetic analyses
of SET domain proteins show that, although these proteins
have homologs in bacteria and archaea, the occurrence is sorare that it is quite unlikely for the last common ancestor to have
had such a protein. Additionally, the SET domains found in bacte-
ria are mostly found in pathogens that are in close contact with eu-
karyotic hosts. The hypothesis then is that bacteria would have
acquired these proteins from a lateral transfer from the eukaryotic
host (Aravind and Iyer, 2003). However, a recent report identifies
SET domain proteins in nonpathogenic bacteria, and phyloge-
netic trees of SET domain proteins do no cluster eukaryotic
SETs with prokaryotic SETs, arguing against the hypothesis of
horizontal gene transfer from the host to the pathogen. Interest-
ingly, a chlamydial SET protein that bears 30% identity in the cat-
alytic domain to many eukaryotic SET domains, was shown to
methylate chlamydial histone-like proteins, and murine histone
H3 (Murata et al., 2007). However, as the authors were only able
to detect the SET protein within the chlamydial cells and not in
the host, the in vivo substrate of this protein remains unknown.
Perspectives
Modulation of host transcription by pathogens is a well-ac-
cepted concept but how specific programs are controlled by
pathogens remains elusive. The fact that, as detailed above, his-
tones can be modified at specific promoters during infection
starts to shed light on this important issue. The challenge that
lies ahead is to determine the molecular mechanisms involved
in bacterially provoked histone modifications. Indeed, to date,
many studies remain at the correlative level. Whether changes
in histone modification are specifically induced by the bacterium
to subvert normal host responses or are the normal host
responses to this pathogen will have to be determined. Many
questions remain unanswered, such as the following: Do bacte-
rial proteins known/predicted to associate with or modify chro-
matin or histones really do so? Do all bacterial factors interacting
with TLR4 induce histone modifications at the promoters of the
same genes as those described for LPS? Do all bacteria that
activate TLR2 have the same effect as Mycobacteria on CIITA
and HLA-DR? Similarly, can other bacteria that block MAPK cas-
cades, such as Yersinia, have a similar inhibitory effect on immu-
nity genes as Shigella? The likely scenario is that multiple signal-
ing cascades converge on the promoters of the affected genes,
and the contribution of each one of them will need to be deter-
mined in future studies.
It is important to note that in addition to the bacterial proteins
described in this Review, a growing category of bacterial
proteins are targeted to the nucleus. For example, cyclomodu-
lins affect the host cell cycle (Oswald et al., 2005), and a bacterial
effector of a plant pathogen, Xanthomonas, acts as a transcrip-
tion factor in its host (Kay et al., 2007; also see the accompanying
Minireview by Saijo and Schulze-Lefert [2008] on page 96).
Whether or not these nuclear targeted effectors also modify
host chromatin remains to be explored.
In conclusion, histone modification and chromatin remodeling
provoked by bacterial pathogens is an emerging and exciting
field of study. Future work will determine how widespread this
phenomenon is and the diversity of mechanisms at work.
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